- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Although Apple shares are no longer cheap, is it fair to deem them overvalued? The answer is probably not.
From Keystone to pharmaceuticals, industrials and energy, the Republican wins in midterm elections create real opportunities investors can take advantage of.
The hysteria surrounding Bill Gross' resignation is causing some investors to make short-sighted, emotional mistakes. But it's time to cut through the hype.
The key is to find stocks that have been incorrectly priced by the market, such as these three.
Always consider international companies that are comparable to their U.S. counterparts to see if one or the other might give your portfolio an edge up on pure domestic plays.
It's mid-year: Here's one standout ETF, plus how to evaluate the others you hold (in addition to equities), to help you weather 2014.
Interest rates will rise and that's not a bad thing.
You can find high-quality, low-volatility, solid, dividend-paying international stocks on your 'home' exchange. Check out the ADR performance for Total, GlaxoSmtihKline, Sanofi and Royal Dutch Shell.
Market rallies can cause as much consternation as corrections and pullback if you don't understand their context.
There are no vast sums of cash on the sidelines. In fact, investors have a negative cash position.